HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Logistics

644.206

-16.730-2.53%

Number of Gainers:1

Number of Losers:8

Number of Flat:3

PE:- -

High:660.840

Open:660.840

Low:644.059

Close:660.936

Volume:19.13M

Turnover:280.94M

Market Cap:343.24B

Float Cap:284.10B

Loading ...

Hong Kong Stock Buyback Summary | November 10

ZTO Express-W (02057) Repurchases 345,000 Shares for $6.43 Million on November 7

Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting

HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

CMSC: E-Commerce Express Sector Sees Expanded Anti-Internalization Results, September Delivery Prices Continue to Rise

Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0

Cyberport Welcomes 10 Newly Listed Firms and Two Unicorn Companies in 2025

KLN Appointed by Ego Pharmaceuticals as 4PL Partner in Hong Kong Strategic Collaboration to Deliver End-to-End Healthcare Supply Chain Solutions

ZTO Express-W Spends $6.57 Million to Repurchase 351,200 Shares on November 4

Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting

China South City Holdings Remains Suspended as Liquidation Proceedings Continue

Sinotrans Limited (601598.SH) Completes Share Buyback of 1.27% Stake for RMB 475 Million

ZTO Express-W (02057) Repurchases 352,900 Shares for $6.6461 Million on November 3

Langfang's Commerce and Logistics Industry Thrives with High-Quality Development Momentum

JD Logistics: Building a Super Supply Chain with Technological "Photosynthesis"

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1541/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1541\",,,,,undefined,":{"symbol":"BK1541","market":"HK","secType":"PLATE","nameCN":"Logistics","latestPrice":644.20605,"timestamp":1763096946311,"preClose":660.9359,"halted":0,"volume":19125901,"delay":0,"changeRate":-0.025312,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-16.729858,"latestTime":"11-14 13:09:15","open":660.83966,"high":660.83966,"low":644.0592,"amount":280937260,"amplitude":0.025389,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1763107800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"pbRate":1.450925,"peRate":14.865453,"turnoverRate":0.001038,"increases":1,"decrements":8,"flats":2,"marketCap":343235431024,"floatMarketCap":284104107824},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1541\",,,,,undefined,":{"symbol":"BK1541","high":660.83966,"amplitude":0.025389,"preClose":660.9359,"low":644.0592,"pbRate":"1.450925","latestPrice":644.20605,"volume":19125901,"delay":0,"open":660.83966,"prevYearClose":578.15375,"prevWeekClose":642.913,"prevMonthClose":632.288,"prevQuarterClose":651.43,"fiveDayClose":642.913,"twentyDayClose":633.928,"sixtyDayClose":664.117,"secType":"PLATE","market":"HK","turnoverRate":0.001038,"peRate":14.865453,"marketCap":343235431024,"floatMarketCap":284104107824,"timestamp":1763096946311,"nameCN":"Logistics"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1541\",,,,undefined,":{"bkCode":"BK1541","up":1,"down":8,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1541\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1179907428","title":"Hong Kong Stock Buyback Summary | November 10","url":"https://stock-news.laohu8.com/highlight/detail?id=1179907428","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179907428?lang=en_us&edition=fundamental","pubTime":"2025-11-10 09:12","pubTimestamp":1762737154,"startTime":"0","endTime":"0","summary":"Several Hong Kong-listed companies conducted share buybacks on November 7, 2025. Among them, China Feihe (06186) recorded the highest buyback amount, repurchasing 6 million shares for HKD 26.08...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B067MR52.USD","LU0359201612.USD","LU0163747925.USD","01358","LU1235295612.USD","IE0034224299.USD","LU0128522157.USD","IE0009570106.USD","BK1517","LU0293314216.USD","LU0737861699.HKD","LU2045819591.USD","BK1209","06826","BK1135","BK1528","LU0211977185.USD","BK1519","BK1161","LU2097828474.EUR","LU0390135688.USD","BK1583","BK1151","BK1253","BK1591","IE00B031J352.USD","02171","BK1574","00732","BK1226","02299","BK1149","SG9999001093.SGD","BK1542","00799","02416","BK1117","IE00B031HY20.USD","IE00B97KM107.HKD","00386","BK1183","BK1197","LU1051769294.HKD","BK1585","02886","02282","02509","BK1103","BK1553","BK1541","02869","LU0348825331.USD","09987","LU1102505762.USD","LU0244354667.USD","LU0072462343.USD","LU1188198961.HKD","BK1599","BK1606","09885","BK1158","SG9999014674.SGD","LU0173614495.USD","00366","BK1607","SG9999001440.SGD","BK1521","IE00B0169L03.USD","LU0417516902.SGD","LU0588546209.SGD","BK1597","LU1102505929.USD","09959","01919","08188","BK1500","LU0828237940.HKD","IE00B29SXG58.USD","LU0049112450.USD","LU0463099449.HKD","LU0348805143.USD","HK0000320223.HKD","LU0259732245.USD","01681","LU1769817179.HKD","01586","00418","LU0251143458.SGD","BK1258","00103","LU0328353924.USD","02142","LU0140636845.USD","02018","BK1104","HK0000320264.USD","LU1023057109.AUD","LU0359202008.SGD","LU1048596156.SGD","BK1535","BK1502","09966","BK1228","LU0594300419.USD","BK1170","IE0008369823.USD","LU0672654166.SGD","BK1233","01167","LU2097828714.EUR","LU2125910500.SGD","02598","LU0315179316.USD","BK1225","HK0000306701.USD","IE0031814852.USD","LU0228659784.USD","LU2097828805.USD","SG9999006597.SGD","02120","BK1588","LU1769817096.USD","LU0390135506.SGD","BK1229","LU1224709979.USD","BK1589","BK1506","SG9999003461.SGD","BK1202","LU0823426308.USD","LU0300738605.USD","BK1526","00947","BK1608","LU0471298777.SGD","01066","BK1593","LU1046422090.SGD","BK1237","LU0543330483.HKD","LU0823426480.USD","LU0651946864.USD","LU0348788117.USD","BK1155","BK1160","BK1222","BK1619","06868","02039","BK1109","LU2097828557.USD","BK1575","01588","00909","BK1137","BK1504","LU0307460666.USD","BK1100","LU0300738514.USD","LU0181495838.USD","LU0320764755.SGD","LU0651947912.USD","BK1587","LU0228367735.SGD","BK1531","LU1051768304.USD","08128","LU0048580855.USD","LU0287142896.SGD","LU1282651048.USD","BK1507","SG9999011746.SGD","LU0029875118.USD","IE0008368742.USD","02469","BK1618","IE0032834883.USD","LU0326950275.SGD","HK0000306685.HKD","LU0370786039.SGD","02486","BK1167","LU0385154629.USD","LU2279701549.SGD","BK1505","BK1562","LU0106959298.USD","02343","BK1518","BK1172","SG9999002950.SGD","LU1439103000.SGD","02319","06186","02190","LU1831875114.USD","02057","LU0821914370.USD","BK1221","LU0359201885.HKD","LU0390135332.USD","BK1516","LU0650527681.SGD","LU1048588211.SGD","LU2097828631.EUR","SG9999002828.SGD","BK1191","LU1515016050.SGD","BK1148","00777"],"gpt_icon":0},{"id":"1162972773","title":"ZTO Express-W (02057) Repurchases 345,000 Shares for $6.43 Million on November 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1162972773","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162972773?lang=en_us&edition=fundamental","pubTime":"2025-11-10 08:18","pubTimestamp":1762733895,"startTime":"0","endTime":"0","summary":"ZTO Express-W (02057) announced that it repurchased 345,000 shares for $6.43 million on November 7, 2025.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK1502","BK1151","BK4505","ZTO","BK1541","LU0417516902.SGD","BK4526","IE00BPRC5H50.USD","BK4502","BK4558","LU0348825331.USD","BK1575","BK4503","IE00B29SXG58.USD","IE00B5MMRT66.SGD","BK4588","IE00B543WZ88.USD","BK4585","BK4131","BK1588","02057"],"gpt_icon":0},{"id":"2581628886","title":"Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581628886","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581628886?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:05","pubTimestamp":1762524300,"startTime":"0","endTime":"0","summary":"40% ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden . Estimate 55% of patients with MSS CRC have high plasma TMB, representing a meaningful population with high unmet need. \"These compelling new Phase 2 data for vilastobart in combination with atezolizumab demonstrated a 40% objective response rate in heavily pre-pretreated patients with MSS mCRC without liver metastases and with high plasma TMB, signifying an important advance in our understanding of response to novel immunotherapy in MSS mCRC,\" said Katarina Luptakova, M.D., chief medical officer of Xilio. \"In addition, these data showed a statistically significant correlation between plasma-based TMB and response. We estimate that approximately 55% of patients with MSS CRC have high plasma TMB, representing a meaningful patient population who could ultimately benefit from combination treatment with vilastobart and a substantially greater prevalence of patients w","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4108","IE00BYQNZ168.SGD","IE0003851619.USD","LU0359201612.USD","BK4022","01698","MSS","BK4571","BK4539","BK4531","BK4231","BK4232","BK4007","BK4548","IE0003795394.USD","BK4526","BK4509","ORR","BK4535","LU2039709279.SGD","BK4080","IE00B12V2V27.USD","LU0456842615.SGD","BK4107","LU1023057109.AUD","BK4585","LU2487616109.SGD","L","SG9999011746.SGD","LU0053666078.USD","R","BK4113","TMB","01308","BK4588","BK4139","SITC","XLO","BK1541","LENZ","BK4563","LU0210528500.USD","BK4552","IE00BYTNYN87.SGD","LU0359202008.SGD","BK4565","TME","BK1103"],"gpt_icon":0},{"id":"2581888667","title":"Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888667","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581888667?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:01","pubTimestamp":1762524060,"startTime":"0","endTime":"0","summary":"Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, including efficient masking, potent anti-tumor activity and b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183720/0/en/Xilio-Therapeutics-Highlights-Portfolio-of-Differentiated-Masked-Immunotherapies-at-Society-for-Immunotherapy-of-Cancer-SITC-40th-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4552","BK1103","BK4080","IE00B12V2V27.USD","LU1169590202.USD","SITC","LU1023057109.AUD","LU0359202008.SGD","BK4563","01308","BK4113","BK4539","IE00BYTNYN87.SGD","LENZ","BK4526","LU0456842615.SGD","BK4139","BK4023","IE0003795394.USD","PD","LU0359201612.USD","BK4571","MSS","SG9999011746.SGD","BK4007","BK4535","BK4565","01698","TME","BK4108","IE00BYQNZ168.SGD","LU1169589451.USD","BK1541","BK4509","BK4548","IE0003851619.USD","BK4531","BK4231","LU2039709279.SGD"],"gpt_icon":0},{"id":"2581886965","title":"IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581886965","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581886965?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:00","pubTimestamp":1762524000,"startTime":"0","endTime":"0","summary":"Pre-clinical data for IO Biotech’s next T-win vaccine candidate, IO112 targeting arginase 1, demonstrates anti-tumor activity with dynamic changes in the tumor microenvironment (TME) driven by the vac","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183674/0/en/IO-Biotech-Presents-Pre-Clinical-Data-Highlighting-the-Potential-of-Additional-Therapeutic-Cancer-Vaccine-Candidates-at-the-2025-Annual-Meeting-of-the-Society-for-Immunotherapy-of-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4526","IE0003795394.USD","LU1023057109.AUD","IE00BYTNYN87.SGD","BK4139","LU0359202008.SGD","IE0003851619.USD","SG9999011746.SGD","LU0359201612.USD","IE00BYQNZ168.SGD","BK4509","BK4535","BK4565","01698","BK4531","BK4552","IE00B12V2V27.USD","LU0456842615.SGD","LU2039709279.SGD","BK4108","TME","01308","BK1103","BK1541","IOBT","BK4571","BK4548"],"gpt_icon":0},{"id":"2581888267","title":"BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888267","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581888267?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:30","pubTimestamp":1762518600,"startTime":"0","endTime":"0","summary":"Next generation Bria-OTS+ platform demonstrates rapid, potent and durable anti-cancer activity by activating both innate and adaptive immune responses Increased tumor cell cytotoxicity induced by both","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183561/0/en/BriaCell-Presents-Robust-Anti-Cancer-Activity-of-Bria-OTS-at-SITC-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4202","BK4139","IE0003851619.USD","BK4080","BK1541","IE0003795394.USD","01308","NCI","BK1103","IE00BYTNYN87.SGD","SG9999011746.SGD","IE00B12V2V27.USD","SITC","IE00BYQNZ168.SGD","BK4231"],"gpt_icon":0},{"id":"2581888114","title":"Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888114","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581888114?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:30","pubTimestamp":1762518600,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, Nov.  07, 2025  (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183563/0/en/Context-Therapeutics-Highlights-CT-95-and-CT-202-Programs-at-2025-SITC-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC","BK1541","IE0003851619.USD","BK4121","BK4539","IE00B19Z4B17.USD","LU1093756325.SGD","IE00B7SZL793.SGD","BK4007","CRS","LU0963586101.USD","BK4588","IE00BYQNZ168.SGD","BK4548","LU2211817866.USD","LU2065731478.USD","LU0347712357.USD","01308","BK4567","BK4139","LU1093756168.USD","IE0003795394.USD","BK4080","MTD","IE0031619046.USD","LU1721428933.USD","BK4585","IE00B66KJ199.SGD","IE00BYTNYN87.SGD","LU2413666699.HKD","BK1103","BK4533","LU2413666426.HKD","BK4231","LENZ","IE00BFXG0V08.USD","SG9999011746.SGD","BK4187","BK4006","IE00B12V2V27.USD","IE00BYQQ9H92.USD"],"gpt_icon":0},{"id":"2581007360","title":"HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581007360","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581007360?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:00","pubTimestamp":1762516800,"startTime":"0","endTime":"0","summary":"Tetra-valent T-cell engager designed to address shortfalls of bi-specific T-cell engagers (BiTE) related to manufacturability, safety profile, and ability to treat a wide spectrum of solid tumorsMIRAM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183532/0/en/HCW-Biologics-Presents-Preclinical-Data-for-TRBC-Based-T-Cell-Engager-Program-at-the-Society-for-Immunotherapy-of-Cancer-s-SITC-40th-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0003795394.USD","BK1541","IE00B12V2V27.USD","01308","IE0003851619.USD","HCWB","BK1103","BK4539","IE00BYQNZ168.SGD","PDX","BK4139","SG9999011746.SGD","IE00BYTNYN87.SGD"],"gpt_icon":0},{"id":"1187402118","title":"CMSC: E-Commerce Express Sector Sees Expanded Anti-Internalization Results, September Delivery Prices Continue to Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=1187402118","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187402118?lang=en_us&edition=fundamental","pubTime":"2025-11-07 15:20","pubTimestamp":1762500031,"startTime":"0","endTime":"0","summary":"According to a research report by CMSC, the express delivery sector recorded a 17.2% year-on-year growth in volume for the first nine months of 2025, with September alone rising 12.7%. However,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","BK0276","06099","BK1588","IE00B29SXG58.USD","BK0183","BK1575","02057","BK1502","BK0188","BK1147","BK1541","BK0012","600999","BK0010","BK0028","BK1151"],"gpt_icon":0},{"id":"2581954740","title":"Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2581954740","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581954740?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:30","pubTimestamp":1762432200,"startTime":"0","endTime":"0","summary":"Leptomeningeal metastases disease session features novel treatments in the horizon, REYOBIQ and ReSPECT-LM, and future directions and needsHOUSTON, Nov.  06, 2025  (GLOBE NEWSWIRE) -- Plus Therapeutic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/06/3182450/0/en/Plus-Therapeutics-Highlights-ReSPECT-LM-Clinical-Trial-Results-at-40th-SITC-Annual-Meeting-Melanoma-Research-Foundation-Brain-Metastases-Summit-4-0.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4202","IE00BYQNZ168.SGD","NCI","BK4231","BK1103","01308","SITC","BK4539","IE00BYTNYN87.SGD","IE0003851619.USD","BK4211","CNS","BK1541","BK4139","IE0003795394.USD","SG9999011746.SGD","SMMF","BK4135","BK4007","IE00B12V2V27.USD","LENZ"],"gpt_icon":0},{"id":"1178665688","title":"Cyberport Welcomes 10 Newly Listed Firms and Two Unicorn Companies in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1178665688","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178665688?lang=en_us&edition=fundamental","pubTime":"2025-11-06 14:06","pubTimestamp":1762409176,"startTime":"0","endTime":"0","summary":"On November 6, the \"2025 Cyberport Venture Capital Forum\" officially commenced in Hong Kong's Cyberport, delving into the new global venture capital landscape driven by artificial intelligence (AI)...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1502","02670","BK1541","BK1617","00636","BK1189","02506","BK1151"],"gpt_icon":0},{"id":"2581714209","title":"KLN Appointed by Ego Pharmaceuticals as 4PL Partner in Hong Kong Strategic Collaboration to Deliver End-to-End Healthcare Supply Chain Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2581714209","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581714209?lang=en_us&edition=fundamental","pubTime":"2025-11-05 13:42","pubTimestamp":1762321320,"startTime":"0","endTime":"0","summary":"HONG KONG, Nov. 5, 2025 /PRNewswire/ -- KLN Logistics Group Limited  is pleased to announce the appointment of its pharmaceutical arm, KLN Pharma  Limited , as the fourth-party logistics  service provider for Australian skincare brand Ego Pharmaceuticals in Hong Kong. Under the partnership, KLN Pharma will manage Ego Pharmaceuticals' entire supply chain operations across a wide range of skincare and pharmaceutical products.Samuel Lau, Managing Director - Integrated Logistics of KLN, said, \"We are thrilled to partner with Ego Pharmaceuticals, a company that exemplifies scientific excellence and sustainable innovation. Our 4PL model offers the agility, compliance and scalability needed to support Ego's growth ambitions in Hong Kong.\". Ted Pitts, Global Supply Chain Manager of Ego Pharmaceuticals, said, \"We are committed to delivering science-backed skincare solutions to consumers across Asia. KLN's logistics expertise and deep understanding of pharmaceutical distribution make them an ide","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/kln-appointed-by-ego-pharmaceuticals-as-4pl-partner-in-hong-kong-strategic-collaboration-to-deliver-end-to-end-healthcare-supply-chain-solutions-302605108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1541","LU0029874061.USD","00636","BK6520","NEX.SI","BK6085","T43.SI","BK1151","BK6515","BK6039","BK4585","BK4588","HCSG","BK1502","BK4581","BK4137","LABU","XLV","XBI","LU0128526141.USD"],"gpt_icon":0},{"id":"1162100426","title":"ZTO Express-W Spends $6.57 Million to Repurchase 351,200 Shares on November 4","url":"https://stock-news.laohu8.com/highlight/detail?id=1162100426","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162100426?lang=en_us&edition=fundamental","pubTime":"2025-11-05 12:50","pubTimestamp":1762318215,"startTime":"0","endTime":"0","summary":"ZTO Express-W (02057) announced that on November 4, 2025, the company repurchased 351,200 shares at a total cost of $6.57 million.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","BK4505","LU0348825331.USD","BK4588","BK1541","BK1575","IE00B543WZ88.USD","IE00B5MMRT66.SGD","ZTO","IE00BPRC5H50.USD","BK4535","IE00B29SXG58.USD","BK4131","BK4503","02057","BK4526","BK4558","BK4585","BK1588","BK1502","BK1151","BK4502"],"gpt_icon":0},{"id":"2580303037","title":"Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2580303037","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580303037?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:05","pubTimestamp":1762265100,"startTime":"0","endTime":"0","summary":"CR-001 Demonstrated Cooperative Pharmacology and Robust Anti-Tumor ActivityIND Submission for CR-001 On Track for Fourth Quarter of 2025 to Support Initiation of Global Phase 1 Trial in Patients with ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180450/0/en/Crescent-Biopharma-to-Present-Preclinical-Data-for-CR-001-a-PD-1-x-VEGF-Bispecific-Antibody-at-the-Society-for-Immunotherapy-of-Cancer-s-SITC-40th-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","IE00B12V2V27.USD","PD","IE0003795394.USD","BK4080","LU1169589451.USD","SITC","IE00BYQNZ168.SGD","SG9999011746.SGD","BK1541","IE0003851619.USD","IE00BYTNYN87.SGD","BK4231","BK1103","LU1169590202.USD","01308"],"gpt_icon":0},{"id":"2580734123","title":"Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2580734123","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580734123?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:00","pubTimestamp":1762261200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov.  04, 2025  (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of syst","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180247/0/en/Calidi-Biotherapeutics-Announces-Investor-Event-to-be-Held-on-Friday-November-7th-at-the-2025-SITC-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B12V2V27.USD","IE0003851619.USD","BK4231","IE0003795394.USD","01308","BK4080","BK1103","IE00BYTNYN87.SGD","SITC","BK1541","SG9999011746.SGD","IE00BYQNZ168.SGD"],"gpt_icon":0},{"id":"2580891067","title":"China South City Holdings Remains Suspended as Liquidation Proceedings Continue","url":"https://stock-news.laohu8.com/highlight/detail?id=2580891067","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580891067?lang=en_us&edition=fundamental","pubTime":"2025-11-04 17:55","pubTimestamp":1762250139,"startTime":"0","endTime":"0","summary":"China South City Holdings Ltd. has announced a change in the date and venue of its upcoming extraordinary general meeting and the withdrawal of an ordinary resolution related to its property management services framework agreement. The company, currently in liquidation, also confirmed that trading of its shares on the Hong Kong Stock Exchange remains suspended as of 4 November 2025 and will continue to be so until further notice. The liquidators have advised shareholders and investors to exercise caution when dealing in the company's securities. For further enquiries, stakeholders are directed to contact the appointed liquidators.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China South City Holdings Ltd. published the original conte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL375wnX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1541","BK1516","01668","BK1240"],"gpt_icon":0},{"id":"1110782468","title":"Sinotrans Limited (601598.SH) Completes Share Buyback of 1.27% Stake for RMB 475 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1110782468","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110782468?lang=en_us&edition=fundamental","pubTime":"2025-11-04 17:42","pubTimestamp":1762249338,"startTime":"0","endTime":"0","summary":"Sinotrans Limited (601598.SH) announced that as of October 31, 2025, the company had repurchased 92.5641 million A-shares via the Shanghai Stock Exchange's centralized bidding system, accounting for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1502","LU0702159343.USD","00598","BK0237","BK1505","BK1151","BK1535","LU1166156734.SGD","BK1541","601598","LU0702159699.USD"],"gpt_icon":0},{"id":"1138636720","title":"ZTO Express-W (02057) Repurchases 352,900 Shares for $6.6461 Million on November 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1138636720","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138636720?lang=en_us&edition=fundamental","pubTime":"2025-11-04 12:36","pubTimestamp":1762230971,"startTime":"0","endTime":"0","summary":"ZTO Express-W (02057) announced that on November 3, 2025, the company repurchased 352,900 shares at a total cost of $6.6461 million.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","BK1541","IE00B29SXG58.USD","BK1151","IE00B5MMRT66.SGD","BK4505","LU0417516902.SGD","ZTO","BK1502","IE00B543WZ88.USD","BK4526","IE00BPRC5H50.USD","BK4502","BK4585","BK4535","BK1588","BK4131","02057","BK4588","BK1575","BK4503","BK4558"],"gpt_icon":0},{"id":"1126028778","title":"Langfang's Commerce and Logistics Industry Thrives with High-Quality Development Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1126028778","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126028778?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:21","pubTimestamp":1762176100,"startTime":"0","endTime":"0","summary":"Leveraging the advantages of Beijing and Tianjin, Langfang is accelerating its industrial transformation during the \"14th Five-Year Plan\" period. The city has capitalized on its unique transportation...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1502","IE00B543WZ88.USD","BK4503","BK1541","BK4588","BK1575","BK4558","IE00BPRC5H50.USD","LU0348825331.USD","ZTO","BK1151","BK4526","IE00B29SXG58.USD","BK4131","BK4535","BK4502","02057","BK1588","IE00B5MMRT66.SGD","LU0417516902.SGD","BK4505","BK4585"],"gpt_icon":0},{"id":"1146762158","title":"JD Logistics: Building a Super Supply Chain with Technological \"Photosynthesis\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1146762158","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146762158?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:11","pubTimestamp":1762168281,"startTime":"0","endTime":"0","summary":"When logistics technology evolves from a mere cost-saving tool into an ecosystem capability that nurtures all aspects of supply chains, a profound transformation is underway. E-commerce platforms and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1502","BK1151","02618","BK1587","BK1604","BK1541"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":60,"code":"91000000","status":"200"}]}}